Carbamic acid, with the specific structure described, is a complex organic compound characterized by the presence of a carbamate functional group, which is derived from carbamic acid. The compound features a butyl ester, indicating that it has a butyl group attached to the carbamic acid moiety, enhancing its lipophilicity and potential bioactivity. The presence of a sulfonyl group suggests that it may exhibit unique chemical reactivity and solubility properties. Additionally, the imidazo[4,5-b]pyridine structure contributes to its potential pharmacological activity, as this class of compounds is often associated with various biological effects. The biphenyl moiety may also influence the compound's stability and interaction with biological targets. Overall, this compound's intricate structure suggests it may have applications in medicinal chemistry, particularly in the development of pharmaceuticals, though specific biological activities and properties would require further investigation through empirical studies.

Carbamic acid,[[4'-[[2-butyl-5-methyl-6-[(1-oxopentyl)amino]-3H-imidazo[4,5-b]pyridin-3-yl]methyl][1,1'-biphenyl]-2-yl]sulfonyl]-, butyl ester

154512-46-6: Carbamic acid, with the specific structure described, is a complex organic compound characterized by the presence of a carbamate functional group, which is derived from carbamic acid. The compound features a butyl ester, indicating that it has a butyl group attached to the carbamic acid moiety, enhancing its lipophilicity and potential bioactivity. The presence of a sulfonyl group suggests that it may exhibit unique chemical reactivity and solubility properties. Additionally, the imidazo[4,5-b]pyridine structure contributes to its potential pharmacological activity, as this class of compounds is often associated with various biological effects. The biphenyl moiety may also influence the compound's stability and interaction with biological targets. Overall, this compound's intricate structure suggests it may have applications in medicinal chemistry, particularly in the development of pharmaceuticals, though specific biological activities and properties would require further investigation through empirical studies.

<p>L162441 is an inhibitor of the protein interactions between peptides and proteins. It binds to the ligand-binding site of the receptor and prevents it from interacting with its natural substrate, thereby blocking signal transduction. L162441 binds to specific receptors in a competitive manner, which has been shown using a high-affinity antibody.<br> L162441 has been used as a research tool for studying the function of ion channels and antibodies. It is also used as a pharmacological agent for treating various types of cancer.</p>

L162441

L162441 is an antagonist of Angiotensin type 1 receptor.

CAS 154512-46-6

Carbamic acid,[[4'-[[2-butyl-5-methyl-6-[(1-oxopentyl)amino]-3H-imidazo[4,5-b]pyridin-3-yl]methyl][1,1'-biphenyl]-2-yl]sulfonyl]-, butyl ester

L162441

Ref: 3D-EGA51246

L162441

Ref: TM-T11809